当前位置:首页 - 行情中心 - 华纳药厂(688799) - 财务分析 - 现金流量表

华纳药厂

(688799)

  

流通市值:74.97亿  总市值:74.97亿
流通股本:1.34亿   总股本:1.34亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金578,869,749.4310,679,596.651,362,698,491.41,000,415,489.13
  收到的税费返还401,793.0762,463.281,000,079.7339,575,062.52
  收到其他与经营活动有关的现金26,972,367.278,562,493.3434,063,501.2545,618,991.68
  经营活动现金流入小计606,243,909.74319,304,553.271,397,762,072.381,085,609,543.33
  购买商品、接受劳务支付的现金46,923,177.7219,966,850.74203,812,379.43112,386,116.57
  支付给职工以及为职工支付的现金105,829,955.0659,207,513.62187,037,942.28142,526,571.5
  支付的各项税费60,721,021.0940,106,020.17143,824,402.8109,257,322.22
  支付其他与经营活动有关的现金226,034,770.02126,971,151.12562,886,837.21515,131,072.18
  经营活动现金流出小计439,508,923.89246,251,535.651,097,561,561.72879,301,082.47
  经营活动产生的现金流量净额166,734,985.8573,053,017.62300,200,510.66206,308,460.86
二、投资活动产生的现金流量:
  收回投资收到的现金569,839,509.59100,041,273.97627,000,000493,000,000
  取得投资收益收到的现金7,929,630.62142,293.8818,137,063.942,826,868.39
  处置固定资产、无形资产和其他长期资产收回的现金净额--74,763.89-
  处置子公司及其他营业单位收到的现金净额--5,969,037.05-9,595,803.06
  投资活动现金流入小计577,769,140.21100,183,567.85651,180,864.88486,231,065.33
  购建固定资产、无形资产和其他长期资产支付的现金299,374,117.86188,689,970.43520,318,123.84339,451,639.65
  投资支付的现金643,029,651.12170,000,000733,472,605.56527,943,400
  支付其他与投资活动有关的现金--6,564,840.11-
  投资活动现金流出小计942,403,768.98358,689,970.431,260,355,569.51867,395,039.65
  投资活动产生的现金流量净额-364,634,628.77-258,506,402.58-609,174,704.63-381,163,974.32
三、筹资活动产生的现金流量:
  吸收投资收到的现金28,797,993-14,974,38314,974,383
  其中:子公司吸收少数股东投资收到的现金---14,974,383
  取得借款收到的现金735,291,891.71174,398,227383,995,846.4238,252,260.74
  筹资活动现金流入小计764,089,884.71174,398,227398,970,229.4253,226,643.74
  偿还债务支付的现金460,852,974.71---
  分配股利、利润或偿付利息支付的现金19,238,800.153,817,650.1262,964,210.3459,762,262.25
  筹资活动现金流出小计480,091,774.863,817,650.1262,964,210.3459,762,262.25
  筹资活动产生的现金流量净额283,998,109.85170,580,576.88336,006,019.06193,464,381.49
四、汇率变动对现金及现金等价物的影响-1,366,483.74-645,151.4-993,338.01-407,517.58
五、现金及现金等价物净增加额84,731,983.19-15,517,959.4826,038,487.0818,201,350.45
  加:期初现金及现金等价物余额201,478,427.66201,478,427.66175,439,940.58175,439,940.58
  期末现金及现金等价物余额286,210,410.85185,960,468.18201,478,427.66193,641,291.03
补充资料:
  净利润64,599,830-228,098,328.6-
  资产减值准备1,065,215.97-8,833,358.42-
  固定资产和投资性房地产折旧37,342,389.79-67,181,107.74-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧37,342,389.79-67,181,107.74-
  无形资产摊销3,160,173.25-3,869,641.72-
  长期待摊费用摊销3,375,479.56-5,775,744.92-
  处置固定资产、无形资产和其他长期资产的损失--413.06-
  固定资产报废损失--27,257.84-
  财务费用1,160,309.04-1,640,703.7-
  投资损失-3,203,427.26--84,456,255.41-
  递延所得税5,948,498.4-1,358,727.34-
  其中:递延所得税资产减少5,948,498.4-1,382,829.87-
    递延所得税负债增加---24,102.53-
  存货的减少11,073,806.21-11,073,650.88-
  经营性应收项目的减少591,941.49--56,444,183.31-
  经营性应付项目的增加34,829,875.54-60,410,018.76-
  其他--51,964,641.89-
  现金的期末余额286,210,410.85-201,478,427.66-
  减:现金的期初余额201,478,427.66-175,439,940.58-
  现金及现金等价物的净增加额84,731,983.19-26,038,487.08-
公告日期2026-08-252026-04-212026-04-212025-10-31
审计意见(境内)标准无保留意见
TOP↑